Most importantly, we found that BSYQ treatment significantly increased the expressions of CRH and CRHR1 in the lesions of AD mice, following increased corticosterone levels and decreased inflammatory cytokine levels. This evidence concerns the gene CRHR1 and Alzheimer disease.